Crescent Biopharma, Inc. (CBIO)
11.85
-0.37
(-3.03%)
USD |
NASDAQ |
Dec 19, 16:00
11.88
+0.03
(+0.25%)
After-Hours: 20:00
Crescent Biopharma Shareholders Equity (Quarterly): 116.64M for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| XOMA Royalty Corp. | 107.96M |
| Viridian Therapeutics, Inc. | 502.97M |
| DiaMedica Therapeutics, Inc. | 51.62M |
| Denali Therapeutics, Inc. | 926.20M |
| Praxis Precision Medicines, Inc. | 343.50M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 138.27M |
| Total Liabilities (Quarterly) | 21.63M |
| Debt to Equity Ratio | 0.0149 |
| Current Ratio | 6.627 |
| Net Debt Paydown Yield | -0.16% |